000			02148 a2200613 4500
005			20250517032643.0
264		0	_c20160425
008			201604s 0 0 eng d
022			_a1522-9645
024	7		_a10.1093/eurheartj/ehv177 _2doi
040			_aNLM _beng _cNLM
100	1		_aCappato, Riccardo
245	0	0	_aUninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation. _h[electronic resource]
260			_bEuropean heart journal _cJul 2015
300			_a1805-11 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAnti-Arrhythmia Agents _xtherapeutic use
650	0	4	_aAtrial Fibrillation _xsurgery
650	0	4	_aBlood Loss, Surgical _xprevention & control
650	0	4	_aCatheter Ablation _xadverse effects
650	0	4	_aDrug Administration Schedule
650	0	4	_aFactor Xa Inhibitors _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOperative Time
650	0	4	_aProspective Studies
650	0	4	_aPulmonary Veins _xsurgery
650	0	4	_aRecurrence
650	0	4	_aReoperation
650	0	4	_aRivaroxaban _xadministration & dosage
650	0	4	_aSingle-Blind Method
650	0	4	_aTreatment Outcome
650	0	4	_aVitamin K _xantagonists & inhibitors
700	1		_aMarchlinski, Francis E
700	1		_aHohnloser, Stefan H
700	1		_aNaccarelli, Gerald V
700	1		_aXiang, Jim
700	1		_aWilber, David J
700	1		_aMa, Chang-Sheng
700	1		_aHess, Susanne
700	1		_aWells, Darryl S
700	1		_aJuang, George
700	1		_aVijgen, Johan
700	1		_aHügl, Burkhard J
700	1		_aBalasubramaniam, Richard
700	1		_aDe Chillou, Christian
700	1		_aDavies, D Wyn
700	1		_aFields, L Eugene
700	1		_aNatale, Andrea
773	0		_tEuropean heart journal _gvol. 36 _gno. 28 _gp. 1805-11
856	4	0	_uhttps://doi.org/10.1093/eurheartj/ehv177 _zAvailable from publisher's website
999			_c24902146 _d24902146